Annual CFF
$129.38 M
+$27.01 M+26.38%
31 December 2022
Summary:
Provention Bio annual cash flow from financing activities is currently $129.38 million, with the most recent change of +$27.01 million (+26.38%) on 31 December 2022. During the last 3 years, it has risen by +$15.09 million (+13.21%).PRVB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$905.00 K
-$113.79 M-99.21%
31 December 2022
Summary:
Provention Bio quarterly cash flow from financing activities is currently $905.00 thousand, with the most recent change of -$113.79 million (-99.21%) on 31 December 2022.PRVB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$129.38 M
+$905.00 K+0.70%
31 December 2022
Summary:
Provention Bio TTM cash flow from financing activities is currently $129.38 million, with the most recent change of +$905.00 thousand (+0.70%) on 31 December 2022.PRVB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRVB Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | +13.2% | +100.0% | +26.0% |
5 y5 years | +118.0% | -98.6% | +105.7% |
PRVB Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time | at high | -99.2% | -40.2% |
Provention Bio Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | $129.38 M(+26.4%) | $905.00 K(-99.2%) | $129.38 M(+0.7%) |
Sept 2022 | - | $114.69 M(+885.8%) | $128.48 M(+832.0%) |
June 2022 | - | $11.63 M(+441.2%) | $13.79 M(+541.2%) |
Mar 2022 | - | $2.15 M(>+9900.0%) | $2.15 M(-97.9%) |
Dec 2021 | $102.38 M(-10.4%) | $0.00(0.0%) | $102.38 M(-0.3%) |
Sept 2021 | - | $0.00(0.0%) | $102.67 M(-0.3%) |
June 2021 | - | $0.00(-100.0%) | $102.95 M(-52.4%) |
Mar 2021 | - | $102.38 M(>+9900.0%) | $216.47 M(+89.4%) |
Dec 2020 | $114.29 M | $291.00 K(+1.4%) | $114.29 M(+0.2%) |
Sept 2020 | - | $287.00 K(-99.7%) | $114.07 M(-35.4%) |
June 2020 | - | $113.52 M(>+9900.0%) | $176.63 M(+179.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | $194.00 K(+173.2%) | $63.13 M(+0.3%) |
Dec 2019 | $62.94 M(+6.1%) | $71.00 K(-99.9%) | $62.94 M(+0.1%) |
Sept 2019 | - | $62.85 M(>+9900.0%) | $62.89 M(+4.7%) |
June 2019 | - | $21.00 K(>+9900.0%) | $60.05 M(+1.2%) |
Mar 2019 | - | $0.00(-100.0%) | $59.35 M(0.0%) |
Dec 2018 | $59.35 M(+122.1%) | $20.00 K(-100.0%) | $59.35 M(+0.0%) |
Sept 2018 | - | $60.01 M(-8911.7%) | $59.33 M(-8824.7%) |
June 2018 | - | -$681.00 K(<-9900.0%) | -$680.00 K(-102.5%) |
Dec 2017 | $26.72 M | $1000.00(>+9900.0%) | $26.72 M(+0.0%) |
Sept 2017 | - | $0.00(-100.0%) | $26.71 M(0.0%) |
June 2017 | - | $26.71 M | $26.71 M |
FAQ
- What is Provention Bio annual cash flow from financing activities?
- What is the all time high annual CFF for Provention Bio?
- What is Provention Bio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Provention Bio?
- What is Provention Bio TTM cash flow from financing activities?
- What is the all time high TTM CFF for Provention Bio?
What is Provention Bio annual cash flow from financing activities?
The current annual CFF of PRVB is $129.38 M
What is the all time high annual CFF for Provention Bio?
Provention Bio all-time high annual cash flow from financing activities is $129.38 M
What is Provention Bio quarterly cash flow from financing activities?
The current quarterly CFF of PRVB is $905.00 K
What is the all time high quarterly CFF for Provention Bio?
Provention Bio all-time high quarterly cash flow from financing activities is $114.69 M
What is Provention Bio TTM cash flow from financing activities?
The current TTM CFF of PRVB is $129.38 M
What is the all time high TTM CFF for Provention Bio?
Provention Bio all-time high TTM cash flow from financing activities is $216.47 M